Caladrius Biosciences, Inc. 4
4 · Caladrius Biosciences, Inc. · Filed Jan 27, 2016
Insider Transaction Report
Form 4
Wei Eric
Director
Transactions
- Award
Options to Purchase Common Stock
2016-01-25+15,000→ 15,000 totalExercise: $0.63From: 2017-01-25Exp: 2026-01-25→ Common Stock (15,000 underlying) - Award
Common Stock
2016-01-25+9,000→ 19,000 total
Holdings
- 2,122,988(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]Represents 9,000 shares of restricted stock granted under the Issuer's 2015 Equity Compensation Plan. The shares of restricted stock will all vest on January 25, 2017.
- [F2]Includes 9,000 shares of unvested restricted stock.
- [F3]2,110,988 shares of Common Stock of the Issuer are held by RimAsia Capital Partners L.P., a Cayman Islands exempted limited partnership ("RimAsia LP"), and 12,000 shares of Common Stock of the Issuer are held by RimAsia Capital Partners Manager, Ltd., a Cayman Islands exempted company ("RimAsia Manager").
- [F4]RimAsia Capital Partners GP, L.P., a Cayman Islands exempted limited partnership ("RimAsia GP"), is the general partner of RimAsia LP. RimAsia Manager is the Fund Manager of RimAsia GP and the Manager of RimAsia LP. Mr. Wei is the managing partner of RimAsia LP, an indirect partner of RimAsia GP, a director of RimAsia Capital Partners GP, Ltd. and a director of RimAsia Manager. As a result, Mr. Wei may be deemed to have sole power to vote certain of the securities held by RimAsia LP and RimAsia Manager. Mr. Wei disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, and the inclusion of these securities shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Securities Exchange Act or for any other purpose.